Skip to main content

CONTRAFECT Corp

CFRXDelisted Dec 27, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001478069

CONTRAFECT Corp was delisted on Dec 27, 2023; its insiders filed their last Form 4 on Feb 16, 2023; 40 institutions reported holding it in 13F filings for Q4 2022, worth $1.08M in total; no superinvestor held it.

Holders of 5% or more of CFRX

Holders whose latest Schedule 13D or 13G filing reports 5% or more of CONTRAFECT Corp, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of CFRX
HolderLatest formStakeChangeFirst filedLatest filingFiling
Armistice Capital, LLC13G9.99%1.19M sharesNewAug 14, 20251 filingAug 14, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

1 Schedule 13D or 13G filing on CONTRAFECT Corp, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CFRX
Filed (ET)FilerFormStakeChangeEvent dateFiling
Aug 14, 20258:54 PM ETArmistice Capital, LLCand 1 other13G9.99%1.19M sharesNewJun 30, 2025SEC
Apr 15, 2021Biotechnology Value Fund L P13G/AOld format–––SEC
Apr 9, 20216:02 PM ETBlackRock Inc.13G/AOld format–––SEC
Feb 16, 2021Altium Capital Management LP13G/AOld format–––SEC
Feb 16, 2021CVI Investments, Inc.13G/AOld format–––SEC
Feb 12, 202112:34 PM ETFederated Hermes, Inc.13G/AOld format–––SEC
Feb 12, 2021Pfizer Inc13G/AOld format–––SEC
Feb 2, 20213:13 PM ETBlackRock Inc.13GOld format–New–SEC
Jan 26, 2021Fosun Industrial Co., Ltd13G/AOld format–––SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell CONTRAFECT Corp shares.

No Form 144 notices for CONTRAFECT Corp are on file.